EX-23.1 2 ex23130503foghornconsent-2.htm EX-23.1

Ex 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-262711 on Form S-3 and Registration Statement Nos. 333-262713 and 333-252119 on Form S-8 of our report dated March 9, 2023, relating to the financial statements of Foghorn Therapeutics Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

March 9, 2023